Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,580.70 +125.86 1.01%
S&P 500 1,332.42 +14.60 1.11%
Nasdaq 2,870.99 +33.46 1.18%
Ticker Volume Price Price Delta
STOXX 50 2,130.78 -29.53 -1.37%
FTSE 100 5,314.39 -76.75 -1.42%
DAX 6,330.08 -66.76 -1.04%
Ticker Volume Price Price Delta
Nikkei 8,633.19 -23.89 -0.28%
TOPIX 723.62 -3.41 -0.47%
Hang Seng 18,690.20 -365.24 -1.92%
Gold 1,549.90 -0.07%
EUR-USD 1.2447 -0.4445%
Nasdaq 2,870.99 +1.18%
DJIA 12,580.70 +1.01%
S&P 500 1,332.42 +1.11%
FTSE 100 5,314.39 -1.42%
STOXX 50 2,130.78 -1.37%
DAX 6,330.08 -1.04%
Oil (WTI) 89.58 -1.30%
U.S. 10-year 1.692% -0.053
BAC:US 7.44 +4.06%
FB:US 28.84 -9.62%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Therapeutics

Warner Chilcott PLC

Add to Portfolio

WCRX:US

20.3300 USD 0.1300 0.64%

As of 20:10:00 ET on 05/29/2012.

Snapshot for Warner Chilcott PLC (WCRX)

Open: 20.1000 Day's Range: 19.9900 - 20.4900 Volume: 3,084,135 Bid: 20.3100
Previous Close: 20.2000 52wk Range: 12.9000 - 24.6500 1-Yr Rtn: -16.27% Ask: 20.3200

Stock Chart for WCRX

No chart data available.
  • WCRX:US 20.3300
  • 1D
  • 1M
  • 1Y
20.2000
Interactive WCRX Chart

Previous Close

Key Statistics for WCRX

Current P/E Ratio (ttm) 12.8671
Estimated P/E (12/2012) 5.8336
Earnings Per Share (USD) (ttm) 1.5800
Est. EPS (USD) (12/2012) 3.4850
Est. PEG Ratio 0.7168
Market Cap (M USD) 5,091.07
Shares Outstanding (M) 250.42
Enterprise Value (M USD) (ttm) 8,157.07
Enterprise Value/EBITDA (ttm) 5.75
Price/Book (mrq) 30.1086
Price/Sale (ttm) 1.9207
Dividend Indicated Gross Yield 0.0000
Next Earnings Announcement 08/06/2012
More WCRX Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for WCRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)
More WCRX Income Statement Data
  • Total Assets
  • Total Liabilities (M/USD)
  • Debt to Assets (%)
More WCRX Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/USD)
More WCRX Cash Flow Data

Company Profile & Key Executives for WCRX

Warner Chilcott PLC is a pharmaceutical company. The Company is focused on marketing, selling, developing and manufacturing branded prescription pharmaceutical products in women's healthcare and dermatology in the United States.

John Alexander KingChairmanRoger M BoissonneaultPresident/CEO
W Carl ReichelPres:PharmaceuticalsPaul S HerendeenExec VP/CFO
More Company Profile & Key Executives for WCRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements